NTLA-2001
Intellia Therapeutics
['crispr']
#aha22 poll time:
given the known dangers of gene editing, would it be acceptable to permanently gene edit cv gene targets when just as effective temporary gene targeting drug alternatives exist that provide the same clinical benefit? #crispr #rnai
Independent Biotech Analyst & Patent Atty. Robert Toczycki, JD, MBA. Developer of online biotech valuation calculators. Chicago native, Go Bears!